https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
0
0
optimus
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
optimus2019-11-28 09:27:082023-06-14 16:07:55European CNS Specialist Neuraxpharm Expands Southern European Presence with Expansion into Portugal
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
0
0
optimus
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
optimus2019-11-26 12:34:392023-06-14 16:08:04Novo Seeds expands company formation activities at BiOrigin with seasoned entrepreneurs
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
0
0
optimus
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
optimus2019-11-22 12:28:442023-06-14 16:14:34IXICO Notice of Results
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
0
0
optimus
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
optimus2019-11-21 12:20:232023-06-14 16:13:58Azeria Therapeutics announces £32.0 million series B financing
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
0
0
optimus
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
optimus2019-11-18 12:18:592023-06-14 16:13:52Castor Establishes Advisory Board of Industry Leaders to Maximize the Impact of its Clinical Data Platform
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
0
0
optimus
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
optimus2019-11-14 12:28:352023-06-14 16:13:45Theragnostics strengthens leadership team with two key appointments
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
0
0
optimus
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
optimus2019-11-14 12:16:172023-06-14 16:08:09Calliditas Interim Report Q3, 2019
https://www.optimumcomms.com/wp-content/uploads/2019/11/F2G_Logo_300x180px-80x80-1.png
180
300
optimus
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
optimus2019-11-11 17:49:142023-10-12 11:11:39F2G Receives US FDA Breakthrough Therapy Designation for Olorofim
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
0
0
optimus
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
optimus2019-11-06 09:26:182023-06-14 16:08:25Artios Pharma, MD Anderson and ShangPharma Announce In-Licensing Agreement for DNA Damage Response Inhibitor
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
0
0
optimus
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
optimus2019-11-05 17:44:162023-06-14 16:08:17IXICO to Present Abstracts at Upcoming Huntington’s Disease and Ataxia Conferences
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
0
0
optimus
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
optimus2019-10-29 10:52:312023-06-14 16:13:28Neuraxpharm enters booming CBD market with the acquisition of leading Switzerland-based S.T.U GMBH
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
0
0
optimus
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
optimus2019-10-28 09:18:332023-06-14 16:13:25IXICO announces client contracts and appointment of Chief Business Officer
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
0
0
optimus
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
optimus2019-10-22 09:55:512023-06-14 16:13:20Kiadis Pharma announces formation of renowned Scientific Advisory Board
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
0
0
optimus
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
optimus2019-10-17 12:28:542023-06-14 16:14:41Verona Pharma Completes Enrollment in Phase 2b Clinical Trial with Nebulized Ensifentrine in moderate-to-severe COPD
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
0
0
optimus
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
optimus2019-10-15 10:17:552023-06-14 16:13:17IXICO Company reports fast tracked achievement of initial year positive EBITDA, 40% revenue growth and strong cash position
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
0
0
optimus
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
optimus2019-10-15 10:14:562023-06-14 16:13:10Verona Pharma to Present Phase 2 Symptom Data with Ensifentrine in COPD at CHEST 2019
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
0
0
optimus
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
optimus2019-10-13 09:59:122023-06-14 16:12:10ISA Pharmaceuticals B.V. receives EUR 20m loan from European Investment Bank
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
0
0
optimus
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
optimus2019-10-07 13:13:352023-06-14 16:13:03Castor Announces International Expansion to Meet Growing Demand for an AI-Powered Clinical Data Platform
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
0
0
optimus
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
optimus2019-10-07 12:27:072023-06-14 16:12:54Owkin publishes breakthrough research in Nature Medicine
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
0
0
optimus
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
optimus2019-10-01 09:54:162023-06-14 16:12:51Positive interactions with EMA provide route to conditional marketing authorization of lead candidate NefeconFor more information about Optimum Strategic Communications, please get in touch.
